Resistant hypertension? Time to consider this fourth-line drug

No Thumbnail Available

Meeting name

Sponsors

Date

Journal Title

Format

Article

Subject

Research Projects

Organizational Units

Journal Issue

Abstract

Resistant hypertension? Time to consider this fourth-line drug For most adults with resistant hypertension, spironolactone is superior to doxazosin and bisoprolol as an adjunct to triple therapy. Practice changer: When a triple regimen of an ACE inhibitor or ARB, calcium channel blocker, and a thiazide diuretic fails to achieve the target blood pressure, try adding spironolactone.

Table of Contents

DOI

PubMed ID

Degree

Thesis Department

Rights

OpenAccess.

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.